MYTESI
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Jul 2023)
What this means for you
Registered since 14 Feb 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87039259
- Registration number
- 5143495
- Mark type
- Stylized text
- Filed
- 17 May 2016
- Published for opposition
- 11 Oct 2016
- Registered
- 14 Feb 2017
- Attorney of record
- Lynn E. Rzonca
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diarrhea; Pharmaceutical preparations for the treatment of diarrhea; Plant extracts for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes
Owner
- Napo Pharmaceuticals, San Francisco, CA, US
- Napo Pharmaceuticals, San Francisco, CA, US
- Napo Pharmaceuticals, San Francisco, CA, US
Prosecution history
- 20 Feb 2026 — TEAS SECTION 8 & 9 RECEIVED
- 15 Feb 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 13 Jul 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Jul 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Jul 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Jan 2023 — TEAS SECTION 8 & 15 RECEIVED
- 26 Nov 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Nov 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Nov 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 Feb 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Feb 2017 — REGISTERED-PRINCIPAL REGISTER
- 11 Jan 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Jan 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Jan 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Dec 2016 — USE AMENDMENT FILED